Loading organizations...
Loading organizations...
High-tech biotechnology company developing mRNA and gene editing drugs.
Yaotang Biology has raised $59.0M across 2 funding rounds.
Yaotang Biology has raised $59.0M in total across 2 funding rounds.
Yaotang Biology has raised $59.0M in total across 2 funding rounds.
Yaotang Biology's investors include AZ-CICC Healthcare Investment Fund, Decheng Capital.
Yaotang Biology has raised $59.0M across 2 funding rounds. Most recently, it raised $45.0M Series B in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 11, 2025 | $45.0M Series B | AZ-CICC Healthcare Investment Fund | |
| Nov 30, 2023 | $14.0M Series A | Decheng Capital |